Role of nitric oxide in the hypersusceptibility to pentylenetetrazole-induced seizure in diazepam-withdrawn mice

Tsuda Makoto, Norifumi Shimizu, Yoshinori Yajima, Tsutomu Suzuki, Miwa Misawa

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

The decrease in the seizure threshold for pentylenetetrazole in diazepam-withdrawn mice was not significantly affected by L-arginine (50 and 100 μg/mouse, i.c.v.), which did have an antiseizure effect in chronically vehicle-treated mice. Sodium nitroprusside (25 and 50 μg/mouse, i.c.v.) increased the seizure threshold for pentylenetetrazole in both diazepam-withdrawn mice and chronically vehicle-treated mice. In addition, the antiseizure effect of L-arginine was blocked by the nitric oxide (NO) synthase inhibitor, N-nitro-L-arginine (NOARG) and the NO scavenger, hemoglobin, while the effect of sodium nitroprusside was inhibited by hemoglobin, but not by NOARG, indicating that the antiseizure effect of L-arginine, but not that of sodium nitroprusside, is mediated by NO production resulting from the activation of NO synthase. Therefore, a decrease in the NO production via NO synthase may be involved in the hypersusceptibility to pentylenetetrazole during diazepam withdrawal.

Original languageEnglish
Pages (from-to)27-30
Number of pages4
JournalEuropean Journal of Pharmacology
Volume344
Issue number1
DOIs
Publication statusPublished - Feb 26 1998
Externally publishedYes

Fingerprint

Pentylenetetrazole
Diazepam
Nitric Oxide
Seizures
Arginine
Nitroprusside
Nitric Oxide Synthase

All Science Journal Classification (ASJC) codes

  • Cellular and Molecular Neuroscience
  • Pharmacology

Cite this

Role of nitric oxide in the hypersusceptibility to pentylenetetrazole-induced seizure in diazepam-withdrawn mice. / Makoto, Tsuda; Shimizu, Norifumi; Yajima, Yoshinori; Suzuki, Tsutomu; Misawa, Miwa.

In: European Journal of Pharmacology, Vol. 344, No. 1, 26.02.1998, p. 27-30.

Research output: Contribution to journalArticle

Makoto, Tsuda ; Shimizu, Norifumi ; Yajima, Yoshinori ; Suzuki, Tsutomu ; Misawa, Miwa. / Role of nitric oxide in the hypersusceptibility to pentylenetetrazole-induced seizure in diazepam-withdrawn mice. In: European Journal of Pharmacology. 1998 ; Vol. 344, No. 1. pp. 27-30.
@article{77943e11464e4a21a291f93a68186877,
title = "Role of nitric oxide in the hypersusceptibility to pentylenetetrazole-induced seizure in diazepam-withdrawn mice",
abstract = "The decrease in the seizure threshold for pentylenetetrazole in diazepam-withdrawn mice was not significantly affected by L-arginine (50 and 100 μg/mouse, i.c.v.), which did have an antiseizure effect in chronically vehicle-treated mice. Sodium nitroprusside (25 and 50 μg/mouse, i.c.v.) increased the seizure threshold for pentylenetetrazole in both diazepam-withdrawn mice and chronically vehicle-treated mice. In addition, the antiseizure effect of L-arginine was blocked by the nitric oxide (NO) synthase inhibitor, N-nitro-L-arginine (NOARG) and the NO scavenger, hemoglobin, while the effect of sodium nitroprusside was inhibited by hemoglobin, but not by NOARG, indicating that the antiseizure effect of L-arginine, but not that of sodium nitroprusside, is mediated by NO production resulting from the activation of NO synthase. Therefore, a decrease in the NO production via NO synthase may be involved in the hypersusceptibility to pentylenetetrazole during diazepam withdrawal.",
author = "Tsuda Makoto and Norifumi Shimizu and Yoshinori Yajima and Tsutomu Suzuki and Miwa Misawa",
year = "1998",
month = "2",
day = "26",
doi = "10.1016/S0014-2999(98)00017-X",
language = "English",
volume = "344",
pages = "27--30",
journal = "European Journal of Pharmacology",
issn = "0014-2999",
publisher = "Elsevier",
number = "1",

}

TY - JOUR

T1 - Role of nitric oxide in the hypersusceptibility to pentylenetetrazole-induced seizure in diazepam-withdrawn mice

AU - Makoto, Tsuda

AU - Shimizu, Norifumi

AU - Yajima, Yoshinori

AU - Suzuki, Tsutomu

AU - Misawa, Miwa

PY - 1998/2/26

Y1 - 1998/2/26

N2 - The decrease in the seizure threshold for pentylenetetrazole in diazepam-withdrawn mice was not significantly affected by L-arginine (50 and 100 μg/mouse, i.c.v.), which did have an antiseizure effect in chronically vehicle-treated mice. Sodium nitroprusside (25 and 50 μg/mouse, i.c.v.) increased the seizure threshold for pentylenetetrazole in both diazepam-withdrawn mice and chronically vehicle-treated mice. In addition, the antiseizure effect of L-arginine was blocked by the nitric oxide (NO) synthase inhibitor, N-nitro-L-arginine (NOARG) and the NO scavenger, hemoglobin, while the effect of sodium nitroprusside was inhibited by hemoglobin, but not by NOARG, indicating that the antiseizure effect of L-arginine, but not that of sodium nitroprusside, is mediated by NO production resulting from the activation of NO synthase. Therefore, a decrease in the NO production via NO synthase may be involved in the hypersusceptibility to pentylenetetrazole during diazepam withdrawal.

AB - The decrease in the seizure threshold for pentylenetetrazole in diazepam-withdrawn mice was not significantly affected by L-arginine (50 and 100 μg/mouse, i.c.v.), which did have an antiseizure effect in chronically vehicle-treated mice. Sodium nitroprusside (25 and 50 μg/mouse, i.c.v.) increased the seizure threshold for pentylenetetrazole in both diazepam-withdrawn mice and chronically vehicle-treated mice. In addition, the antiseizure effect of L-arginine was blocked by the nitric oxide (NO) synthase inhibitor, N-nitro-L-arginine (NOARG) and the NO scavenger, hemoglobin, while the effect of sodium nitroprusside was inhibited by hemoglobin, but not by NOARG, indicating that the antiseizure effect of L-arginine, but not that of sodium nitroprusside, is mediated by NO production resulting from the activation of NO synthase. Therefore, a decrease in the NO production via NO synthase may be involved in the hypersusceptibility to pentylenetetrazole during diazepam withdrawal.

UR - http://www.scopus.com/inward/record.url?scp=0032568078&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032568078&partnerID=8YFLogxK

U2 - 10.1016/S0014-2999(98)00017-X

DO - 10.1016/S0014-2999(98)00017-X

M3 - Article

VL - 344

SP - 27

EP - 30

JO - European Journal of Pharmacology

JF - European Journal of Pharmacology

SN - 0014-2999

IS - 1

ER -